Towards host-directed therapies for tuberculosis
dc.contributor.author | Wejse, C. | |
dc.contributor.author | Petersen, E. | |
dc.contributor.author | Kaleebu, P. | |
dc.contributor.author | Oliver, M. | |
dc.contributor.author | Craig, G. | |
dc.contributor.author | Corrah, T. | |
dc.contributor.author | Tientcheu, L. | |
dc.contributor.author | Antonio, M. | |
dc.contributor.author | Rao, M. | |
dc.contributor.author | McHugh, T.D. | |
dc.contributor.author | Sheikh, A. | |
dc.contributor.author | Zumla, A. | |
dc.contributor.author | Maeurer, M. | |
dc.contributor.author | Chakaya, J. | |
dc.contributor.author | Hoelscher, M. | |
dc.contributor.author | Ntoumi, F. | |
dc.contributor.author | Rustomjee, R. | |
dc.contributor.author | Vilaplana, C. | |
dc.contributor.author | Yeboah-Manu, D. | |
dc.contributor.author | Rasolofo, V. | |
dc.contributor.author | Munderi, P. | |
dc.contributor.author | Singh, N. | |
dc.contributor.author | Aklillu, E. | |
dc.contributor.author | Padayatchi, N. | |
dc.contributor.author | Macete, E. | |
dc.contributor.author | Kapata, N. | |
dc.contributor.author | Mulenga, M. | |
dc.contributor.author | Kibiki, G. | |
dc.contributor.author | Mfinanga, S. | |
dc.contributor.author | Nyirenda, T. | |
dc.contributor.author | Maboko, L. | |
dc.contributor.author | Garcia-Basteiro, A. | |
dc.contributor.author | Rakotosamimanana, N. | |
dc.contributor.author | Bates, M. | |
dc.contributor.author | Mwaba, P. | |
dc.contributor.author | Reither, K. | |
dc.contributor.author | Gagneux, S. | |
dc.contributor.author | Edwards, S. | |
dc.contributor.author | Mfinanga, E. | |
dc.contributor.author | Abdulla, S. | |
dc.contributor.author | Cardona, P.-J | |
dc.contributor.author | Russell, J.B.W. | |
dc.contributor.author | Gant, V. | |
dc.contributor.author | Noursadeghi, M. | |
dc.contributor.author | Elkington, P. | |
dc.contributor.author | Bonnet, M. | |
dc.contributor.author | Menendez, C. | |
dc.contributor.author | Dieye, T.N. | |
dc.contributor.author | Diarra, B. | |
dc.contributor.author | Maiga, A. | |
dc.contributor.author | Aseffa, A. | |
dc.contributor.author | Parida, S. | |
dc.contributor.author | Ippolito, G. | |
dc.contributor.author | Ramjee, G. | |
dc.contributor.author | Kaufmann, S.H.E. | |
dc.contributor.author | Churchyard, G. | |
dc.contributor.author | Steyn, A. | |
dc.contributor.author | Grobusch, M. | |
dc.contributor.author | Sanne, I. | |
dc.contributor.author | Martinson, N. | |
dc.contributor.author | Madansein, R. | |
dc.contributor.author | Wilkinson, R.J. | |
dc.contributor.author | Mayosi, B. | |
dc.contributor.author | Schito, M. | |
dc.contributor.author | Wallis, R.S. | |
dc.date.accessioned | 2018-09-13T10:20:39Z | |
dc.date.available | 2018-09-13T10:20:39Z | |
dc.date.issued | 2015-08 | |
dc.description.abstract | The treatment of tuberculosis is based on combinations of drugs that directly target Mycobacterium tuberculosis. A new global initiative is now focusing on a complementary approach of developing adjunct host-directed therapies | en_US |
dc.identifier.other | DOI: 10.1038/nrd4696 | |
dc.identifier.uri | http://ugspace.ug.edu.gh/handle/123456789/24123 | |
dc.language.iso | en | en_US |
dc.publisher | Nature Reviews Drug Discovery | en_US |
dc.subject | Tuberculosis | en_US |
dc.subject | Mycobacterium tuberculosis | en_US |
dc.subject | antibiotic | en_US |
dc.subject | drug-resistant | en_US |
dc.subject | pharmacokinetic | en_US |
dc.subject | immune reconstitution inflammatory syndrome (IRIS) | en_US |
dc.title | Towards host-directed therapies for tuberculosis | en_US |
dc.type | Other | en_US |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.6 KB
- Format:
- Item-specific license agreed upon to submission
- Description: